Compared to the new federal transparency and the advance explanation of benefit requirements, reference-based pricing, combined with expert participant representation, is much more likely to succeed at managing employer and participant medical spend.
If you field questions and concerns from plan administrators on excessive medical costs, you know that a common issue facing health plans today is price transparency.
Plan sponsors and their participants currently lack access to information about fees and quality.
That can increase financial fragility as a barrier to obtaining the best care at the best price.
Thus, even minimal improvements in transparency may improve clinical and cost outcomes.
A quality health plan should provide easy, direct access and understanding of pricing, benefits and out-of-pocket expense information so plan participants can make informed and cost-effective decisions.
New federal laws mandate the provision of information that can make this a reality for all.
By taking advantage of this legislation, plan sponsors can empower participants to become effective healthcare consumers, enabling them to proactively manage their care, compare provider fees, obtain an estimate of the benefits and their out-of-pocket costs so as to make cost-conscious decisions and achieve savings — if the sponsors can motivate the participants to shop for care.
Price Transparency Rules
Transparency in Coverage, final rules, a set of regulations released by the U.S. Department of Health and Human Services, is intended to improving price and quality transparency in health care.
The requirements provide pricing information directly from providers through their health plans.
Starting Jan. 1, 2021, the Centers for Medicare and Medicaid Services mandated that hospitals, health systems and other medical providers provide clear, accessible pricing information online about the items and services they provide.
Under CMS guidance and final rules, pricing information must be available in machine-readable format.
This includes a list of shoppable services typically non-emergency treatment that is scheduled in advance.
Advanced Explanation of Benefits
The No Surprises Act also requires health plans and insurers to provide an "advanced explanation of benefits," or AEOB, to the covered participant member for all scheduled services prior to services being rendered, regardless of whether the services are in or out-of-network.
The AEOB must be issued within certain timeframes after the provider submits to the plan or insurer a "good faith estimate," or GFE, of charges for each service.
AEOB is the only document that would give participants sufficient information so that they can identify the actual costs they will incur for non-emergency treatment.
What It Means: Promise vs. Reality
The inherent promise in price transparency and the advance explanation of benefits requirement is better health outcomes and moderation of the ever-increasing cost of care.
This can be achieved through improved patient-consumer decision-making, care coordination, and customer experience.
The reality of price transparency is that patient-consumers alone cannot lead efforts for change using nebulous estimates of potential savings.
However, greater price transparency will have little value unless participants actually shop for medical care.
That would require a dramatic change in patient behavior.
Transparency, therefore, in the form of pricing data alone won't prompt a change in patient behavior, particularly when plan design follows traditional forms of point of purchase cost sharing — deductibles and coinsurance.
Christine Cooper is the CEO of 
